Home > Back to Publisher > Report Information

Scrip's Pharmaceutical Company League Tables 2007

Informa Healthcare
September 1, 2007
118 Pages - SKU: IFHC1693944

Abstract Table of Contents Search inside this report Related Reports

Scrip Pharmaceutical Company League Tables 2007 allows pharma and biotech companies to benchmark their performance against their direct competitors in the industry. Rankings of performance by sales, income, investment and growth and the interactive pivot tables, mean companies can assess performance across a variety of measures.

It is an annual report that is updated to provide tables of ranking on the most important financial criteria used to evaluate company performance. Detailing the financial results for almost 200 companies in both the pharmaceutical and biotechnology industries, Scrip Pharmaceutical Company League Tables 2007 is compiled from extensive primarily research and official company records.

This report allows you to see at a glance how the world’s top pharmaceutical companies performed in 2006 in terms of total revenue, pharmaceutical sales, profitability, R&D expenditure, capital expenditure and growth within these areas.

It incorporates data on the major Western pharmaceutical and biotechnology companies for the 2006 financial year (1st January 2006-31st December 2006). It also features companies whose financial year ends on 31st March 2007, allowing the inclusion of many important companies within the Asian markets, including Astellas, Takeda, Yamanouchi, Dr Reddy. All figures have been converted from domestic currencies into US dollars and ranked in descending order to ease comparisons.

At over 250 pages and containing no less than 30 tables, the League Tables is the perfect way to analyse the trends and patterns within the pharmaceutical industry.

Features:

Analysis of the financial results of the major pharma and biotech companies worldwide for 2006, including Japanese companies and many private companies
Rankings of industry players by sales, revenue and R&D investment
Excel pivot tables to allow you to perform your own analysis over a five-year period.

This new, updated annual report will allow you to:

Benchmark your performance against direct competitors
Compare and analyse their performance of your competitors
Save hours of research
Analyse market trends, movements and plan future business strategies.

CHAPTER 1 METHODOLGY AND DEFINITIONS: 1.1 What are Scrip’s Pharmaceutical Company League Tables?; 1.2 How is the data collected?
CHAPTER 2 LEADING COMPANIES RANKED BY TOTAL REVENUE: 2.1 Commentary
CHAPTER 3 LEADING COMPANIES RANKED BY GROWTH IN TOTAL REVENUE: 3.1 Commentary
CHAPTER 4 LEADING COMPANIES RANKED BY TOTAL SALES: 4.1 Commentary
CHAPTER 5 LEADING COMPANIES RANKED BY PHARMACEUTICAL SALES: 5.1 Commentary
CHAPTER 6 LEADING COMPANIES RANKED BY SHARE OF THE PHARMACEUTICAL MARKET: 6.1 Commentary
CHAPTER 7 LEADING COMPANIES RANKED BY TOTAL OPERTAING PROFIT: 7.1 Commentary
CHAPTER 8 LEADING COMPANIES RANKED BY TOTAL OPERATING PROFIT MARGIN: 8.1 Commentary
CHAPTER 9 LEADING COMPANIES RANKED BY NET PROFIT: 9.1 Commentary
CHAPTER 10 LEADING COMPANIES RANKED BY EARNINGS PER SHARE: 10.1 Commentary
CHAPTER 11 LEADING COMPANIES RANKED BY INCOME PER EMPLOYEE: 11.1 Commentary
CHAPTER 12 LEADING COMPANIES RANKED BY PHARMACEUTICAL OPERATING PROFIT: 12.1 Commentary
CHAPTER 13 LEADING COMPANIES RANKED BY PHARMACEUTICAL OPERATING PROFIT MARGIN: 13.1 Commentary
CHAPTER 14 LEADING COMPANIES RANKED BY TOTAL R&D EXPENDITURE: 14.1 Commentary
CHAPTER 15 LEADING COMPANIES RANKED BY TOTAL R&D EXPENDITURE AS A PERCENTAGE OF TOTAL SALES: 15.1 Commentary
CHAPTER 16 LEADING COMPANIES RANKED BY TOTAL R&D EXPENDITURE AS A PERCENTAGE OF TOTAL REVENUE: 16.1 Commentary
CHAPTER 17 LEADING COMPANIES RANKED BY PHARMACEUTICAL R&D EXPENDITURE: 17.1 Commentary
CHAPTER 18 LEADING COMPANIES RANKED BY TOTAL CAPITAL EXPENDITURE: 18.1 Commentary
CHAPTER 19 LEADING COMPANIES RANKED BY SELLING, GENERAL AND ADMINISTRATIVE EXPENSES: 19.1 Commentary
CHAPTER 20 LEADING COMPANIES RANKED BY TOTAL ASSETS: 20.1 Commentary
CHAPTER 21 LEADING COMPANIES RANKED BY CURRENT ASSETS: 21.1 Commentary
CHAPTER 22 LEADING COMPANIES RANKED BY WORKING CAPITAL: 22.1 Commentary
CHAPTER 23 LEADING COMPANIES RANKED BY PHARMACEUTICAL ASSETS: 23.1 Commentary
CHAPTER 24 LEADING BIOTECHNOLOGY COMPANIES RANKED BY TOTAL REVENUE: 24.1 Commentary
CHAPTER 25 LEADING BIOTECHNOLOGY COMPANIES RANKED BY R&D EXPENDITURE: 25.1 Commentary
CHAPTER 26 LEADING BIOTECHNOLOGY COMPANIES RANKED BY R&D EXPENDITURE AS A PERCENTAGE OF TOTAL REVENUE: 26.1 Commentary
APPENDIX 1 EXCHANGE RATES 2005 AND 2006
APPENDIX 2 MERGERS & ACQUISITIONS OF NOTE
LIST OF TABLES: Table 2.1 Leading Companies Ranked by Total Revenue; Table 3.1 Leading Companies Ranked by Growth in Total Revenue; Table 4.1 Leading Companies Ranked by Total Sales; Table 5.1 Leading Companies Ranked by Pharmaceutical Sales; Table 6.1 Leading Companies Ranked by Share of the Pharmaceutical Market; Table 7.1 Leading Companies Ranked by Total Operating Profit; Table 8.1 Leading Companies Ranked by Total Operating Profit Margin; Table 9.1 Leading Companies Ranked by Net Profit; Table 10.1 Leading Companies Ranked by Earnings per Share; Table 11.1 Leading Companies Ranked by Income per Employee; Table 12.1 Leading Companies Ranked by Pharmaceutical Operating Profit; Table 13.1 Leading Companies Ranked by Pharmaceutical Operating Profit Margin; Table 14.1 Leading Companies Ranked by Total R&D Expenditure; Table 15.1 Leading Companies Ranked by Total R&D Expenditure as a Percentage of Total Sales; Table 16.1 Leading Companies Ranked by Total R&D Expenditure as a Percentage of Total Revenue; Table 17.1 Leading Companies Ranked by Pharmaceutical R&D Expenditure; Table 18.1 Leading Companies Ranked by Total Capital Expenditure; Table 19.1 Leading Companies Ranked by Selling, General and Administrative (SG&A) Expenses; Table 20.1 Leading Companies Ranked by Total Assets; Table 21.1 Leading Companies Ranked by Current Assets; Table 22.1 Leading Companies Ranked by Working Capital; Table 23.1 Leading Companies Ranked by Pharmaceutical Assets; Table 24.1 Leading Biotechnology Companies Ranked by Total Revenue; Table 25.1 Leading Biotechnology Companies Ranked by R&D Expenditure; Table 26.1 Leading Biotechnology Companies Ranked by R&D Expenditure as a Percentage of Total Revenue

Scrip's Pharmaceutical Company League Tables 2007

Share this report

Other tasks

Research Assistance

Related Markets

Research & Development Reports

Free Alert Me service